S
Scholar Rock
Biotech & Life Sciences · Cambridge, United States · Founded 2012 · IPO 2018
Clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a… MoreLess
Scholar Rock is a biopharmaceutical company focused on developing innovative treatments for diseases by targeting protein growth factors. Operating in the healthcare and biotechnology market, Scholar Rock serves patients and healthcare providers by offering novel therapeutic solutions. The company leverages its unique drug discovery platform to unlock new possibilities in disease treatment, particularly in areas that have been historically overlooked. Scholar Rock's business model revolves around research and development, partnerships, and collaborations with other biopharmaceutical companies and institutions. Revenue is generated through licensing agreements, milestone payments, and eventual product sales. The company is committed to patient-centric approaches and values scientific curiosity and collaboration.
Keywords: biopharmaceutical, protein growth factors, innovative treatments, drug discovery, healthcare, biotechnology, patient-centric, research and development, partnerships, collaborations.
Company overview
Scholar Rock company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2012
- Headquarters
- Cambridge, United States
- Employees
- 351
- Open positions
- 20
- Dealroom signal
- 93.3
Valuation & funding
Scholar Rock funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBTDebt | Mar 2026 | $0 | — | Blue Owl Capital | ↗ |
| POST IPO EQUITYOther financing | Oct 2024 | $300M | — | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Oct 2023 | $85M | — | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Jun 2022 | $205M | — | Polaris Partners · Redmile Group · Invus · Samsara BioCapital | ↗ |
| POST IPO DEBTDebt | Oct 2020 | $50M | — | Oxford Finance · Silicon Valley Bank | — |
| IPOOther financing | May 2018 | Undisclosed | ↗ | ||
| SERIES COther financing | Jan 2018 | Invus | — | ||
| SERIES BOther financing | Jan 2016 | Fidelity Investments | — | ||
| SERIES AOther financing | Sep 2014 | The Kraft Group · Polaris Partners · EcoR1 Capital · ARCH Venture Partners | — | ||
| SEEDOther financing | Jan 2013 | Polaris Partners | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $6.5M | — | −$369M | -5674.2% |
| 2025 | $0 | — | −$369M | — |
| 2024 | $0 | — | −$250M | — |
| 2023 | $0 | -100% | −$168M | — |
| 2022 | $33M | +76.4% | −$134M | -404.8% |
| 2021 | $19M | +22.2% | −$127M | -676.5% |
| 2020 | $15M | — | −$87M | -564% |
Growth signals
Scholar Rock website traffic
Latest recorded traffic for Scholar Rock is 20K monthly website visits, up 81.8% over the last three months. Scholar Rock's team grew 5.1% over the past year.
Hiring
Open positions at Scholar Rock
Current openings linked to this company in Dealroom.
Comparisons
Scholar Rock compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Scholar Rock's talent
Source: Dealroom Talent Intelligence.
Investors
14 investors on Scholar Rock's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Scholar Rock has talent and traffic
team presence
In the news
Latest news about Scholar Rock
Recent press, funding announcements, and product moves mentioning Scholar Rock — open to read from the original sources.
Market sentiment
What the market is saying about Scholar Rock
An AI-synthesized read of the highest-engagement posts about Scholar Rock on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Scholar Rock’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.